Frag 176-191 + CJC-1295 + Ipamorelin | Metabolic & GHS Blend | Elite Peptide Supply

• Fragment 176-191 (hGH Lipolytic Fragment): A specific portion of the growth hormone molecule studied for its ability to target beta-3 adrenergic receptors (ADRB3). Research suggests it may amplify fat oxidation in adipose cells and stimulate thermogenesis in skeletal muscle without influencing blood glucose levels.
• CJC-1295 (Mod GRF 1-29 / No DAC): A modified version of GHRH (1-29) optimized for superior pharmacokinetics. Studies indicate it may elevate endogenous GH production by 200-1000% and increase plasma IGF-1 concentrations by up to 3-fold.
• Ipamorelin: A highly selective pentapeptide Growth Hormone Secretagogue. It emulates the hunger hormone, ghrelin, to stimulate the pituitary gland while maintaining a negligible influence on cortisol, prolactin, or aldosterone—making it a gold standard for “clean” GH research.

• Targeted Lipolysis: Investigating the breakdown of lipids via ADRB3 pathways alongside elevated GH levels.
• Hormonal Optimization: Studying the interaction between GHRH analogs (CJC) and Ghrelin mimetics (Ipamorelin) for pulsatile GH release.
• Metabolic Thermogenesis: Analyzing energy expenditure and heat production in skeletal muscle cells.
• Selective Pituitary Signaling: Observing GH secretion patterns without the interference of stress hormones like cortisol.

• Blend Components: Frag 176-191, CJC-1295 (No DAC), Ipamorelin
• Frag 176-191 Formula: C78H125N23O23S2 (1817.1 g/mol)
• CJC-1295 Formula: C152H252N44O42 (3367.95 g/mol)
• Ipamorelin Formula: C38H49N9O5 (711.86 g/mol)
• Purity: ≥99% (HPLC Verified)